BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28490809)

  • 1. Hepatic estrogen receptor α is critical for regulation of gluconeogenesis and lipid metabolism in males.
    Qiu S; Vazquez JT; Boulger E; Liu H; Xue P; Hussain MA; Wolfe A
    Sci Rep; 2017 May; 7(1):1661. PubMed ID: 28490809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of oestrogen and progesterone effects on lipid and carbohydrate metabolism: alteration in the insulin: glucagon molar ratio and hepatic enzyme activity.
    Mandour T; Kissebah AH; Wynn V
    Eur J Clin Invest; 1977 Jun; 7(3):181-7. PubMed ID: 19260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic glucose intolerance precedes hepatic steatosis in the male aromatase knockout (ArKO) mouse.
    Van Sinderen ML; Steinberg GR; Jørgensen SB; To SQ; Knower KC; Clyne CD; Honeyman J; Chow JD; Herridge KA; Jones ME; Simpson ER; Boon WC
    PLoS One; 2014; 9(2):e87230. PubMed ID: 24520329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
    Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
    PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HNF-4α regulated miR-122 contributes to development of gluconeogenesis and lipid metabolism disorders in Type 2 diabetic mice and in palmitate-treated HepG2 cells.
    Wei S; Zhang M; Yu Y; Xue H; Lan X; Liu S; Hatch G; Chen L
    Eur J Pharmacol; 2016 Nov; 791():254-263. PubMed ID: 27592052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
    Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
    J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.
    Dong R; Yang X; Wang C; Liu K; Liu Z; Ma X; Sun H; Huo X; Fu T; Meng Q
    Phytomedicine; 2019 Feb; 53():134-142. PubMed ID: 30668392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy.
    Kim JY; Jo KJ; Kim OS; Kim BJ; Kang DW; Lee KH; Baik HW; Han MS; Lee SK
    Life Sci; 2010 Sep; 87(11-12):358-66. PubMed ID: 20655933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated tissue omega-3 fatty acid status prevents age-related glucose intolerance in fat-1 transgenic mice.
    Romanatto T; Fiamoncini J; Wang B; Curi R; Kang JX
    Biochim Biophys Acta; 2014 Feb; 1842(2):186-91. PubMed ID: 24211484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action.
    Matic M; Bryzgalova G; Gao H; Antonson P; Humire P; Omoto Y; Portwood N; Pramfalk C; Efendic S; Berggren PO; Gustafsson JÅ; Dahlman-Wright K
    PLoS One; 2013; 8(2):e57458. PubMed ID: 23451233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of ESR1 alters the expression of genes regulating hepatic lipid and carbohydrate metabolism in male rats.
    Khristi V; Ratri A; Ghosh S; Pathak D; Borosha S; Dai E; Roy R; Chakravarthi VP; Wolfe MW; Karim Rumi MA
    Mol Cell Endocrinol; 2019 Jun; 490():47-56. PubMed ID: 30974146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.
    Yan H; Yang W; Zhou F; Li X; Pan Q; Shen Z; Han G; Newell-Fugate A; Tian Y; Majeti R; Liu W; Xu Y; Wu C; Allred K; Allred C; Sun Y; Guo S
    Diabetes; 2019 Feb; 68(2):291-304. PubMed ID: 30487265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
    Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
    J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferulic acid improves lipid and glucose homeostasis in high-fat diet-induced obese mice.
    Naowaboot J; Piyabhan P; Munkong N; Parklak W; Pannangpetch P
    Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):242-50. PubMed ID: 26541794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytes.
    Budick-Harmelin N; Anavi S; Madar Z; Tirosh O
    Lipids Health Dis; 2012 Jul; 11():66. PubMed ID: 22676303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular effects of ER alpha- and beta-selective agonists on regulation of energy homeostasis in obese female Wistar rats.
    Weigt C; Hertrampf T; Kluxen FM; Flenker U; Hülsemann F; Fritzemeier KH; Diel P
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):147-58. PubMed ID: 23871901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet.
    Wada T; Kenmochi H; Miyashita Y; Sasaki M; Ojima M; Sasahara M; Koya D; Tsuneki H; Sasaoka T
    Endocrinology; 2010 May; 151(5):2040-9. PubMed ID: 20211973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor.
    Yu L; Wang Z; Huang M; Li Y; Zeng K; Lei J; Hu H; Chen B; Lu J; Xie W; Zeng S
    Biochim Biophys Acta; 2016 Sep; 1859(9):1100-1111. PubMed ID: 26455953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.